Comparative effectiveness of aripiprazole and olanzapine on neurocognitive profile of patients with schizophrenia
Background: Schizophrenia causes significant neurocognitive impairment. Treatment with antipsychotics leads to improvement in psychopathology and neurocognitive functions. Aim: To see comparative effectiveness of aripiprazole and olanzapine on neurocognitive profile of patients with schizophrenia. M...
Saved in:
Main Authors: | Sanya Sharma, Ajeet Sidana, Shivangi Mehta, Manoj Kumar Bajaj |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-10-01
|
Series: | Indian Journal of Psychiatry |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/indianjpsychiatry.indianjpsychiatry_303_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and safety of aripiprazole oral solution in the acute treatment of schizophrenia in Chinese patients
by: Zhen Mao, et al.
Published: (2024-12-01) -
Peripheral blood complement factors C2 and C3 as biomarkers of clinical efficacy in patients with first-episode schizophrenia after aripiprazole treatment
by: Yin Cao, et al.
Published: (2024-12-01) -
Metformin for neurocognitive dysfunction in schizophrenia: a systematic review
by: Zhen-Juan Qin, et al.
Published: (2025-01-01) -
Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas
by: Edward Mignone, et al.
Published: (2025-01-01) -
Influence of ABCB1 polymorphisms on aripiprazole and dehydroaripiprazole plasma concentrations
by: Francisco José Toja-Camba, et al.
Published: (2025-01-01)